A Dual-Color Fluorescence-Based Platform to Identify Selective Inhibitors of Akt Signaling
Aranzazú Rosado, Fabian Zanella, Beatriz Garcia et al. · 2008
Read A Dual-Color Fluorescence-Based Platform to Identify Selective Inhibitors of Akt Signaling by Aranzazú Rosado, Fabian Zanella, Beatriz Garcia et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001823.txt.
Introduction
Aranzazú Rosado, Fabian Zanella, Beatriz Garcia, and their co-authors built a screening platform for cancer drug candidates in a 2008 PLOS ONE research article. Inhibiting Akt signaling is considered one of the most promising therapeutic strategies for many cancers. Cell-based drug screens, though, had historically been compromised by the absence of suitable controls to judge selectivity.
Their dual-color fluorescence platform identifies selective inhibitors of Akt signaling, comparing treated pathway activity against a built-in reference. The full text gives the cell system and the screen results. A screen that reports selectivity from the start saves the common failure of finding a potent drug that is toxic to everything.
Catalog record
| CREATOR | Aranzazú Rosado, Fabian Zanella, Beatriz Garcia et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001823
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
A Dual-Color Fluorescence-Based Platform to Identify Selective Inhibitors of Akt Signaling Authors: Aranzazú Rosado, Fabian Zanella, Beatriz Garcia, Amancio Carnero, Wolfgang Link Published: 2008, PLOS ONE DOI: 10.1371/journal.pone.0001823 ABSTRACT Inhibition of Akt signaling is considered one of the most promising therapeutic strategies for many cancers. However, rational target-orientated approaches to cell based drug screens for anti-cancer agents have historically been compromised by the notorious absence of suitable control cells. In order to address this fundamental problem, we have developed BaFiso, a live-cell screening platform to identify specific inhibitors of this pathway. BaFiso relies on the co-culture of isogenic cell lines that have been engineered to sustain interleukin-3 independent survival of the parental Ba/F3 cells, and that are individually tagged with different fluorescent proteins. Whilst in the first of these two lines cell survival in the absence of IL-3 is dependent on the expression of activated Akt, the cells expressing constitutively-activated Stat5 signaling display IL-3 independent growth and survival in an Akt-independent manner. Small molecules can then be screened in these lines to identify inhibitors that rescue IL-3 dependence. BaFiso measures differential cell survival using multiparametric live cell imaging and permits selective inhibitors of Akt signaling to be identified. BaFiso is a platform technology suitable for the identification of small molecule inhibitors of IL-3 mediated survival signaling. INTRODUCTION Cell-based screens have been widely used in drug discovery although historically, these assays are conducted using genetically diverse cell lines derived from human tumors [1] , [2] . Since the complex intracellular signaling networks that drive cancer cell growth and survival have begun to be elucidated, a more rational approach to drug discovery has become feasible [3] . However, the implementation of target-orientated cell-based screens for anti-cancer drugs remains a challenge, both because of their reliance on defined genetic changes and because of the lack of proper control cells. To overcome this fundamental problem, we have developed a rational strategy for cell-based drug discovery that is based on the convenience and flexibility of the Ba/F3 cell system, an immortalized IL-3-dependent pro-B lymphoblastic cell line [4] . IL-3 supports the growth and survival of Ba/F3 cells through the activation of distinct signaling pathways. Upon binding to its cognate receptor IL-3 activates the Janus kinase signal transduction and transcriptional activation pathways (JAK/STAT) to induce Bcl-x L [5] . Similarly, IL-3 activation of the PI3K/Akt pathway is involved in inhibiting the intrinsic apoptotic machinery in Ba/F3 cells [6] – [8] . Overexpression of several constitutively active signaling molecules abrogates the dependence of these cells on IL-3 [9] . Hence, we generated isogenic cell lines derived from Ba/F3 (BaFiso) in which IL-3 independent survival is sustained by independent signaling events. Each of these isogenic lines was genetically labeled with a fluorescent reporter and thus, the ratio of two spectrally distinct cell populations could be used as primary endpoint of the system to monitor pathway-specific cytotoxicity. Accordingly compounds can be screened in co-cultures of these lines and the change in the relative cell number of the two lines readily and rapidly measured to identify those molecules that specifically interact with one of the signaling pathways. In this instance, BaFiso has been designed as a live-cell system suitable to identify specific inhibitors of Akt signaling. RESULTS The BaFiso system is a dual fluorescence cell-based screening system in which compounds can be readily monitored thanks to the stable expression of yellow or cyan fluorescent proteins that individually tag each of the isogenic cell lines ( Fig. 1 ). To introduce the genes encoding the different fluorescent proteins into Ba/F3 cells, retroviral supernatants were generated by transfection of LinX packaging cells. Through clonal propagation, we were able to establish Ba/F3 cell lines that robustly and homogeneously expressed ECFP ( Fig. 2A and B ) or EYFP ( Fig. 2C and D ). Stable transfectants of these proteins were FACS-sorted to ensure that they expressed similar levels of the fluorescent reporter protein. BaFiso consists of paired isogenic cell lines that have been engineered to acquire IL-3 autonomous growth through constitutive activation of Akt or Stat5 signaling. The two cell lines to be compared are individually tagged with either yellow or cyan fluorescent proteins. Equal numbers of yellow and cyan cells were co-cultured, treated with compounds and the change in the relative cell number was calculated on the basis of the distinct fluorescent proteins measured. Our strategy aims to identify lead compounds that specifically kill test cells with activated Akt signaling (yellow cells) and that spare the otherwise isogenic control cells (cyan cells). Ba/F3 cells were transduced with retroviral supernatant carrying pBabePuro-EYFP or pBabePuro-ECFP. Cell clones were established and sorted in a fluorescence activated cell sorter (FACS) to generate lines homogeneously expressing the corresponding fluorescent tags. (A) and (C), viable Ba/F3 cells show robust and homogeneous expression of the respective fluorescent protein. (B) and (D), corresponding light field views. (E), Generation of stable BaFiso cell lines. Clonal Ba/F3 cells stably expressing EYFP (BY) or ECFP (BC) were used to generate stable BaFiso cell lines that co-express yellow fluorescence and myr-Akt (BYA), or cyan fluorescence and STAT5A1*6 (BCS). Cell clones were established and analyzed. (F), Analysis of transgene expression and downstream activation of the corresponding signaling pathways by western blotting. Antibodies against total Akt, Stat5a, Flag phospho-Akt (Ser473), phospho-p70 S6 (Thr389) and Pim-1 were used and the signals normalized to the respective α-tubulin levels. GENERATION OF DOUBLE STABLE BA/F3 CELL LINES The strategy described here is based on paired isogenic cell lines whose survival in the absence of IL-3 is sustained by the activation of independent signaling pathways. Several signaling pathways have been implicated in IL-3-mediated survival, including those involving Akt and Stat5 [10] , [11] . In order to introduce constitutively active forms of these genes into our dual fluorescence cell-based system, we used retroviral constructs carrying a myristoylated derivate of Akt and STAT5A1*6, which contains two activating amino acid substitutions [11] . The yellow labeled Ba/F3 cells were used to generate Akt-dependent reporter cells whereas the cyan tagged cells were used to establish PI3K/Akt independent reporter cells. The retroviral supernatants of LinX packaging cells were employed to transduce Ba/F3/EYFP cells (BY) with myr-Akt and Ba/F3/ECFP cells (BC) with STAT5A1*6 ( Fig. 2E ). Stably expressing cell clones were selected and the expression of the transgenes was confirmed by western blot analysis ( Fig. 2F ). The level of Akt expression was monitored using an antibody that recognizes Akt irrespective of its phosphorylation state. Akt migrates as a single band with an apparent molecular weight of 60 kDa, although a larger protein was also identified in immunoblots of Akt from lysates of BYA cells. This additional form can be explained by the difference in size produced by the myristoylation signal present in the constitutive active form of Akt used to generate the BYA cell line. Despite the Stat5a protein present in the parental BC cells, ectopic expression of the constitutively active form of Stat5a in BCS cells could be unequivocally demonstrated in western blots probed with an antibody directed against the Flag-tag. Indeed, STAT5A1*6 expression also increased the total Stat5a protein level in BCS cells as shown by immunoblotting using an antibody recognizing Stat5. To examine whether PI3K/Akt or Stat5 signaling is indeed